ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2415

Evaluating the Readability and Comprehension of Patient Education Materials for Systemic Lupus Erythematosus (SLE) Available Online

Nagoor Shaik, Ugochukwu Nweke and Meenakshi Jolly, Rush University, Chicago

Meeting: ACR Convergence 2025

Keywords: education, patient, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2377–2436) Systemic Lupus Erythematosus – Diagnosis, Manifestations, & Outcomes Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic Lupus Erythematosus (SLE) is a chronic multisystemic autoimmune disease that had multidimensional adverse effects on patients lives, and preferentially inflicts young women, specially of color. Patient education materials (PEMs) help patients understand their condition and manage it better. However, these materials frequently exceed the reading ability of the general population, posing challenges for individuals with limited health literacy. The National Institutes of Health (NIH) and the American Medical Association (AMA) recommend that PEMs be written at or below a 6th-grade reading level. We aimed to evaluate the readability and comprehension of SLE-related PEMs available online from both nonprofit and for-profit organizations.

Methods: We analyzed the SLE PEMs from four nonprofit organizations (American College of Rheumatology-ACR, Lupus Foundation of America-LFA, Lupus Research Alliance-LRA, and Lupus Society of Illinois-LSI) and three for-profit companies (Aurinia, AstraZeneca, and GlaxoSmithKline). Readability and comprehension scores were calculated using six standard tools, and group-level comparisons were performed using one-way ANOVA followed by Tukey’s post-hoc analysis. A p-value of ≤0.05 was considered significant.

Results: The average Flesch–Kincaid Grade Level and Flesch Reading Ease scores across all patient education materials (PEMs) were 10.05 ± 0.7 and 52.68 ± 4.1, respectively. On average, materials from nonprofit organizations had a Flesch–Kincaid Grade Level of 10.3 ± 0.8 and a Reading Ease score of 51.1 ± 4.9, whereas for-profit organizations had a slightly lower Grade Level of 9.9 ± 0.4 and a higher Ease score of 54.3 ± 2.6. These differences were not statistically significant (p = 0.51 and 0.20respectively). However significant within-group differences were observed. Among nonprofit organizations, PEMs from the Lupus Foundation of America (LFA) had the best reading and comprehension metrics: (Flesch–Kincaid Grade Level of 9.1 ± 0.4 and a Reading Ease score of 58.3 ± 3.1), as compared to ACR (10.6 ± 0.5, 49.8 ± 2.2), LRA (10.5 ± 0.6, 50.5 ± 2.6), and LSI (11.2 ± 0.4, 45.6 ± 2.0) (p < 0.01). Among for-profit organizations, reading and comprehension levels for PEMs from Aurinia were significantly better in reading and comprehension (Flesch Kincaid Grade level 9.5 ± 0.4 and Reading Ease score of 55.7 ± 3.0), than AstraZeneca (9.9 ± 0.3, 53.1 ± 2.4) and GSK (9.8 ± 0.2, 54.2 ± 2.1) (both p < 0.001).

Conclusion: Most SLE patient education materials online (from both nonprofit and for-profit organizations) are written at or above 10th grade level. These findings highlight the urgent need to improve the reading and comprehension of patient education resources to better assist individuals in understanding and managing their health.

Supporting image 1


Disclosures: N. Shaik: None; U. Nweke: None; M. Jolly: LRA, 1, Rush University, 9, 10.

To cite this abstract in AMA style:

Shaik N, Nweke U, Jolly M. Evaluating the Readability and Comprehension of Patient Education Materials for Systemic Lupus Erythematosus (SLE) Available Online [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/evaluating-the-readability-and-comprehension-of-patient-education-materials-for-systemic-lupus-erythematosus-sle-available-online/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/evaluating-the-readability-and-comprehension-of-patient-education-materials-for-systemic-lupus-erythematosus-sle-available-online/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology